Latest Emmaus Medical Inc. Stories

2014-01-07 08:30:43

TORRANCE, Calif., Jan. 7, 2014 /PRNewswire/ -- Emmaus Medical, Inc. (the "Company," or "Emmaus"), a biopharmaceutical company engaged in the discovery, development and commercialization of innovative and cost-effective treatments and therapies primarily for rare and orphan diseases, today announced it has completed all patient visits for its Phase 3 clinical trial for the treatment of sickle cell disease. Emmaus expects top-line data from the Phase 3 clinical trial to be available in...

2010-05-18 07:00:00

LOS ANGELES, May 18 /PRNewswire/ -- Emmaus Medical, Inc., the privately-held pharmaceutical company developing and bringing to market a promising new treatment for sickle cell disease, announced today that Henry (Hank) McKinnell Jr., PhD, has joined the board of directors. Dr. McKinnell is the former chief executive officer and former chairman of the board of directors of Pfizer Inc. The announcement comes as the company pursues final FDA approval of its sickle cell disease treatment....

2008-07-05 21:00:05

By Melissa Evans After years of clinical trials and research, Dr. Yutaka Niihara came up with a treatment for sickle cell anemia that was so simple he almost didn't believe it. L-Glutamine, one of the most common amino acids produced in the body and found abundantly in protein-rich foods, bloated the sickle- shaped cells that cause immense pain for thousands of people who suffer from the disease. "It's such a simple and safe treatment," said Niihara, who made the discovery while...

Word of the Day
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.